Acurx Pharmaceuticals, Inc.
ACXP· Nasdaq
ACXPAcurx Pharmaceuticals, Inc.
Who holds Acurx Pharmaceuticals, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 31.1K | ±0% | $48.2K | 0% | Aug 13, 2026 |
| Geode Capital Management, LLC | 26.4K | +6.4% | $40.9K | 0% | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 16.2K | ±0% | $25.1K | 0% | Aug 13, 2026 |
| Jane Street Group, LLC | 15.7K | −71.2% | $24.4K | 0% | Aug 14, 2026 |
| Prospect Financial Services LLC | 13.8K | ±0% | $21.4K | 0.1% | Aug 6, 2026 |
| Morgan Stanley | 7.5K | +15.4% | $11.6K | 0% | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 2.7K | +166.1% | $4.3K | 0.1% | Aug 11, 2026 |
| Wells Fargo & Company | 2.3K | ±0% | $3.6K | 0% | Aug 14, 2026 |
| Westside Investment Management, Inc. | 1.7K | ±0% | $2.6K | 0.1% | Jul 27, 2026 |
| NBC Securities, Inc. | 1.5K | ±0% | $2.3K | 0.1% | Jul 21, 2026 |
| Barclays PLC | 281 | −26.1% | $436 | 0% | Aug 14, 2026 |
| Cornerstone Planning Group LLC | 167 | ±0% | $245 | 0% | Jul 29, 2026 |
| Osaic Holdings, Inc. | 100 | ±0% | $155 | 0% | Aug 14, 2026 |
| Group One Trading LLC | 95 | −61.2% | $147 | 0% | Aug 14, 2026 |
| BlackRock, Inc. | 60 | ±0% | $93 | 0% | Aug 7, 2026 |
| Caitong International Asset Management Co., Ltd | 23 | New | $36 | 0% | Aug 5, 2026 |
| SBI Securities Co., Ltd. | 6 | ±0% | $9 | 0% | Jul 23, 2026 |
| UBS Group AG | 3 | −100.0% | $5 | 0% | Aug 13, 2026 |
| NewEdge Advisors, LLC | 0 | New | $0 | 0% | Aug 12, 2026 |
